Showing results (131-140 of 237) with videos related to

Sort By:
Pageof 24
Plos One|January 10, 2013
Feasibility of azacitidine added to standard chemotherapy in older patients with acute myeloid leukemia--a randomised SAL pilot studyUtz Krug, Anja Koschmieder, Daniela Schwammbach, et al.
Transplantation and Cellular Therapy|April 13, 2026
Survival trends in young adults with acute leukaemia after AHSCT in Germany: comparisons with younger and older patientsJochen J Frietsch, Sarah Flossdorf, Ashrafossadat Ahmadian, et al.
Hemasphere|January 26, 2023
Outcome Prediction in Patients With Large B-cell Lymphoma Undergoing Chimeric Antigen Receptor T-cell TherapyConrad-Amadeus Voltin, Philipp Gödel, Laura Beckmann, et al.
Cancers|November 26, 2022
Efficacy of COVID-19 Booster Vaccines in Patients with Hematologic Malignancies: Experiences in a Real-World ScenarioCarolin Krekeler, Lea Reitnauer, Ulrike Bacher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2024
Improvements in Posttransplant Outcomes Over Two Decades in Older Patients with Acute Myeloid Leukemia in the EBMT ALWP StudyAli Bazarbachi, Myriam Labopin, Nour Moukalled, et al.
Bone Marrow Transplantation|April 13, 2024
Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation from sibling and unrelated donors in patients with acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Ryszard Swoboda, et al.
Experimental Hematology|June 15, 2015
MYST2 acetyltransferase expression and Histone H4 Lysine acetylation are suppressed in AMLTim Sauer, Maria Francisca Arteaga, Fabienne Isken, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2012
Prognostic factors affecting outcome after allogeneic transplantation for hematological malignancies from unrelated donors: results from a randomized trialJürgen Finke, Claudia Schmoor, Wolfgang A Bethge, et al.
The Lancet. Haematology|March 19, 2018
Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: retrospective follow-up of an open-label, randomised phase 3 trialFrederick Fasslrinner, Johannes Schetelig, Andreas Burchert, et al.
The Lancet. Haematology|July 9, 2017
Hepatic adverse event profile of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukaemia: results from the open-label, randomised, phase 3 INO-VATE studyHagop M Kantarjian, Daniel J DeAngelo, Anjali S Advani, et al.
Pageof 24